These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4208416)

  • 21. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity.
    Wright PW; Ortiz de Landazuri M; Herberman RB
    J Natl Cancer Inst; 1973 Apr; 50(4):947-54. PubMed ID: 4574190
    [No Abstract]   [Full Text] [Related]  

  • 23. Antigenic characteristics of murine leukemia induced by chemical carcinogens.
    Colnaghi MI; Della Porta G
    Bibl Haematol; 1973; 39():595-602. PubMed ID: 4591438
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.
    Shellam GR; Knight RA
    Nature; 1974 Nov; 252(5481):330-2. PubMed ID: 4372543
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
    Silagi S; Newcomb EW; Weksler ME
    Cancer Res; 1974 Jan; 34(1):100-4. PubMed ID: 4358536
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.
    De Landazuri MO; Herberman RB
    J Natl Cancer Inst; 1972 Jul; 49(1):147-54. PubMed ID: 5037432
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigenic structure of spontaneous lymphatic leukemia cells in mice of the inbred AKR strain.
    Harlozinska A; Richter R
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):801-29. PubMed ID: 4111117
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct comparison of three isotopic release microtoxicity assays as measures of cell-mediated immunity to Gross virus-induced lymphomas in rats.
    Oldham RK; Ortaldo JR; Holden HT; Herberman RB
    J Natl Cancer Inst; 1977 Apr; 58(4):1061-7. PubMed ID: 300436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virion and non-virion murine leukemia membrane antigens: analysis with virus-absorbed antisera.
    Moroni C; Robert-Guroff M; Martin D
    Intervirology; 1974; 3(5-6):292-304. PubMed ID: 4443190
    [No Abstract]   [Full Text] [Related]  

  • 30. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 31. Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma.
    Hanna MG; Tennant RW; Yuhas JM; Clapp NK; Batzing BL; Snodgrass MJ
    Cancer Res; 1972 Oct; 32(10):2226-34. PubMed ID: 4117035
    [No Abstract]   [Full Text] [Related]  

  • 32. Synergy in proliferative and cytotoxic responses of WF rats to syngeneic Gross virus-induced lymphoma cells in vitro.
    Wright PW; Loop SM; Bernstein ID
    J Natl Cancer Inst; 1980 Feb; 64(2):303-8. PubMed ID: 6965510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of viral implication in experimental leukemia induced by n-nitrosobutylurea in mice.
    Imamura N
    Gan; 1973 Feb; 64(1):47-57. PubMed ID: 4718409
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors.
    Glaser M; Kirchner H; Herberman RB
    Int J Cancer; 1975 Sep; 16(3):384-93. PubMed ID: 1176200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific antigenicity of tumors and immunological tolerance in the rat induced by Friend, Gross, and Rauscher viruses.
    Kobayashi H; Kuzumaki N; Gotoda E; Takeichi N; Sendo F
    Cancer Res; 1973 Jul; 33(7):1598-603. PubMed ID: 4124486
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor induction by immunologically activated murine leukemia virus.
    Armstrong MY; Ruddle NH; Lipman MB; Richards FF
    J Exp Med; 1973 May; 137(5):1163-79. PubMed ID: 4144984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
    Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
    J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic comparison of bovine type C virus with murine and feline leukemia viruses.
    Ferrer JF
    Cancer Res; 1972 Sep; 32(9):1871-7. PubMed ID: 4345040
    [No Abstract]   [Full Text] [Related]  

  • 39. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods].
    Lezhneva OM
    Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.